サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1562199

北米の迅速検査キット：2030年までの市場予測 - 地域分析 - タイプ、製品、技術、用途、エンドユーザー別

North America Rapid Test Kit Market Forecast to 2030 - Regional Analysis - by Type, Product, Technology, Application, and End User

出版日
ページ情報
英文 157 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
北米の迅速検査キット：2030年までの市場予測 - 地域分析 - タイプ、製品、技術、用途、エンドユーザー別
出版日: 2024年07月04日
発行: The Insight Partners
ページ情報: 英文 157 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の迅速検査キット市場は、2022年に68億6,940万米ドルと評価され、2030年には104億6,282万米ドルに達すると予測され、2022年から2030年までのCAGRは5.4%を記録すると推定されます。

遺伝病と感染症の流行が北米の迅速検査キット市場を活性化

MJH Life Sciences社（米国）の2022年の報告書によると、世界では毎年30万人の新生児が鎌状赤血球症で生まれていると推定されています。CDCによると、アフリカ系アメリカ人の500人に1人が鎌状赤血球症を患っています。世界保健機関（WHO）が発表した最新の世界マラリア報告（WMR）2022によると、2021年に世界で新たに報告されたマラリア患者は約2億4,700万人で、2020年には2億4,500万人でした。同資料によると、2021年のマラリアによる死亡者数は619,000人でした。

Sickle SCANは、鎌状赤血球貧血を高い感度と特異度で同定するための迅速検査です。迅速診断検査（RDT）は、ヒト血液中のマラリア原虫の存在を検出することで、マラリアの診断に役立ちます。質の高い顕微鏡検査サービスへのアクセスが限られている場合、臨床診断や顕微鏡による診断の代替として放射線診断技術が使用されます。COVID-19の大流行は、迅速検査キット市場に大きな影響を与えました。ほぼすべての診断検査で、SARS-CoV-2感染の症状を示した人々の検査にリアルタイムPCRが使用されました。迅速検査キットはほぼどこにでもあり、堅牢で信頼性が高いです。遺伝子型判定、クローニング、一塩基変異解析のために特定のDNAストレッチの増幅を伴う迅速検査技術は、ほとんどの分子生物学研究所で使用されています。このように、遺伝病や感染症の罹患率の増加が迅速検査キット市場の成長を後押ししています。

北米の迅速検査キット市場概要

研究や治療におけるCRISPRやPCRなどの遺伝子合成・編集ツールの急速な普及により、迅速な定量、改変、観察に役立つアッセイが必要とされています。公的機関や民間団体から多額の資金を求める米国は、先進的な調査手法に多額の投資を行い、迅速検査キット市場で主導的な地位を占めると予想されます。パンデミックのSARS-CoV-2デルタ優勢期とオミクロン優勢期の間に、家庭での検査使用が急増しました。CDCによると、2023年4月には米国全体で7,000万個以上の検査キットが出荷されました。

北米の迅速検査キット市場の収益と2030年までの予測（金額）

北米の迅速検査キット市場セグメンテーション

北米の迅速検査キット市場は、タイプ、製品、技術、用途、エンドユーザー、国によって区分されます。タイプ別では、北米の迅速検査キット市場は迅速抗原検査、迅速抗体検査、その他に区分されます。迅速抗原検査セグメントは2022年に最大の市場シェアを占めました。

製品別では、北米の迅速検査キット市場は市販用迅速検査キットと業務用迅速検査キットに二分されます。市販用迅速検査キット分野は2022年に大きな市場シェアを占めました。

技術別では、北米の迅速検査キット市場は、ラテラルフローアッセイ、固相、凝集、イムノスポットアッセイ、細胞成分ベースに区分されます。2022年には、ラテラルフローアッセイセグメントが最大の市場シェアを占めました。

用途別では、北米の迅速検査キット市場は血糖値検査、感染症検査、妊娠・不妊検査、心代謝検査、その他に分類されます。血糖値検査セグメントが2022年に最大の市場シェアを占めました。

エンドユーザー別では、北米の迅速検査キット市場は、病院・診療所、在宅医療、診断センター、その他に区分されます。病院・診療所セグメントが2022年に最大の市場シェアを占めました。

国別では、北米の迅速検査キット市場は米国、カナダ、メキシコに区分されます。米国が2022年の北米の迅速検査キット市場シェアを独占しました。

F.Hoffmann-La Roche Ltd、Becton Dickinson and Co、ARKRAY Inc、Fujirebio Europe NV、bioMerieux SA、Cepheid、Meril Life Sciences Pvt Ltd、QIAGEN NV、OraSure Technologies Inc、Guangzhou Wondfo Biotech Co Ltd、Denka Co Ltd、Abbott Laboratories、Trinity Co、Abbott Laboratories、Trinity Biotech Plc、SD Biosensor Inc、Bio-Rad Laboratories Inc、Hologic Inc、DiaSorin SpA、Beckman Coulter Incは、北米の迅速検査キット市場で事業を展開する主要企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の迅速検査キット市場：主要産業力学

  • 市場促進要因
    • 遺伝性疾患および感染性疾患の有病率の上昇
    • メーカーによる戦略的イニシアチブ
  • 市場抑制要因
    • 結果の正確性に関する不確実性
  • 市場機会
    • PCR技術への嗜好の高まり
  • 今後の動向
    • 迅速抗原検査における技術革新
  • 影響分析

第5章 迅速検査キット市場：北米市場分析

  • 迅速検査キット市場の収益、2020年～2030年

第6章 北米の迅速検査キット市場分析：タイプ別

  • 迅速抗原検査
  • 迅速抗体検査
  • その他

第7章 北米の迅速検査キット市場分析：製品別

  • 市販用迅速検査キット
  • 業務用迅速検査キット

第8章 北米の迅速検査キット市場分析：技術別

  • ラテラルフローアッセイ
  • 固相
  • 凝集
  • イムノスポットアッセイ
  • 細胞成分ベース

第9章 北米の迅速検査キット市場分析：用途別

  • 血糖値検査
  • 感染症検査
  • 循環代謝検査
  • 妊娠および不妊検査
  • その他

第10章 北米の迅速検査キット市場分析：エンドユーザー別

  • 病院および診療所
  • 診断センター
  • 在宅医療
  • その他

第11章 北米の迅速検査キット市場：国別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ

第12章 業界情勢

  • 迅速検査キット市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第13章 企業プロファイル

  • F. Hoffmann-La Roche Ltd
  • Becton Dickinson and Co
  • ARKRAY Inc
  • Fujirebio Europe NV
  • bioMerieux SA
  • Cepheid
  • Meril Life Sciences Pvt Ltd
  • QIAGEN NV
  • OraSure Technologies Inc
  • Guangzhou Wondfo Biotech Co Ltd
  • Denka Co Ltd
  • Abbott Laboratories
  • Trinity Biotech Plc
  • SD Biosensor Inc
  • Bio-Rad Laboratories Inc
  • Hologic Inc
  • DiaSorin SpA
  • Beckman Coulter Inc

第14章 付録

図表

List Of Tables

  • Table 1. Rapid Test Kits Market Segmentation
  • Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 4. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 5. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 6. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 7. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 8. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 9. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 10. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 11. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 12. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 13. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 14. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 15. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 16. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 17. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 18. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 19. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 20. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 21. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
  • Table 22. Recent Organic Growth Strategies in the Rapid Test Kit Market

List Of Figures

  • Figure 1. Rapid Test Kits Market Segmentation, By Country
  • Figure 2. Rapid Test Kits Market: Key Industry Dynamics
  • Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)
  • Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)
  • Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)
  • Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)
  • Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)
  • Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. North America: Rapid Test Kits Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 30. North America: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 31. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 33. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 34. Growth Strategies in the Rapid Test Kit Market
目次
Product Code: BMIRE00030521

The North America rapid test kit market was valued at US$ 6,869.40 million in 2022 and is expected to reach US$ 10,462.82 million by 2030; it is estimated to record a CAGR of 5.4% from 2022 to 2030.

Rising Prevalence of Genetic and Infectious Diseases Fuels North America Rapid Test Kit Market

A 2022 report by MJH Life Sciences (US) estimates that 300,000 newborns worldwide are born with sickle cell disease every year. According to the CDC, 1 in 500 African Americans is affected by sickle cell disease. The latest World Malaria Report (WMR) 2022 from the World Health Organization (WHO) states that nearly 247 million new malaria cases were reported in the world in 2021, in comparison to 245 million cases that were logged in 2020. According to the same source, the number of deaths caused due to malaria was 619,000 in 2021.

Sickle SCAN is a rapid test for the identification of sickle cell anemia with high sensitivity and specificity. Rapid diagnostic tests (RDTs) help diagnose malaria by detecting the presence of malarial parasites in human blood. Where access to high-quality microscopy services is limited, radiological diagnosis techniques are used as an alternative for clinical or microscope-based diagnosis. The COVID-19 pandemic had a significant impact on the rapid test kits market. Nearly all diagnostic tests used real-time PCR for testing people who showed symptoms of SARS-CoV-2 infection. Rapid test kits are nearly ubiquitous, robust, and reliable. Rapid testing techniques that involve the amplification of specific stretches of DNA for genotyping, cloning, and single nucleotide variation analysis are used in most molecular biology labs. Thus, the increasing incidence of genetic and infectious diseases propels the growth of the rapid test kits market.

North America Rapid Test Kit Market Overview

The rapid adoption of gene synthesis and editing tools such as CRISPR and PCR in research and therapeutics necessitates assays that are helpful in terms of rapid quantification, alterations, and observation. The US, seeking significant funding from public and private organizations, is expected to invest significantly in advanced research methodologies and is expected to be in the leading position in the rapid test kits market. There was a rapid increase in at-home test use occurred between the SARS-CoV-2 Delta- and Omicron-predominant periods of the pandemic. According to the CDC, in April 2023, more than 70 million test kits were shipped across the US.

North America Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million)

North America Rapid Test Kit Market Segmentation

The North America rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the North America rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022.

In terms of product, the North America rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022.

By technology, the North America rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022.

Based on application, the North America rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022.

In terms of end user, the North America rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022.

Based on country, the North America rapid test kit market is segmented into the US, Canada, and Mexico. The US dominated the North America rapid test kit market share in 2022.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, SD Biosensor Inc, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the North America rapid test kit market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Rapid Test Kits Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Genetic and Infectious Diseases
    • 4.1.2 Strategic Initiatives by Manufacturers
  • 4.2 Market Restraints
    • 4.2.1 Uncertainties Related to Accuracy of Results
  • 4.3 Market Opportunities
    • 4.3.1 Increasing Preference for PCR Techniques
  • 4.4 Future Trends
    • 4.4.1 Innovations in Rapid Antigen Tests
  • 4.5 Impact Analysis

5. Rapid Test Kits Market - North America Market Analysis

  • 5.1 Overview
  • 5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030

6. North America Rapid Test Kits Market Analysis - by Type

  • 6.1 Overview
  • 6.2 Rapid Antigen Testing
    • 6.2.1 Overview
    • 6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Rapid Antibody Testing
    • 6.3.1 Overview
    • 6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Rapid Test Kits Market Analysis - by Product

  • 7.1 Overview
  • 7.2 Over-the-Counter Rapid Testing Kit
    • 7.2.1 Overview
    • 7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Professional Rapid Testing Kit
    • 7.3.1 Overview
    • 7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Rapid Test Kits Market Analysis - by Technology

  • 8.1 Overview
  • 8.2 Lateral Flow Assay
    • 8.2.1 Overview
    • 8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Solid Phase
    • 8.3.1 Overview
    • 8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Agglutination
    • 8.4.1 Overview
    • 8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Immunospot Assay
    • 8.5.1 Overview
    • 8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cellular-Component Based
    • 8.6.1 Overview
    • 8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Rapid Test Kits Market Analysis - by Application

  • 9.1 Overview
  • 9.2 Blood Glucose Testing
    • 9.2.1 Overview
    • 9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Infectious Disease Testing
    • 9.3.1 Overview
    • 9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Cardiometabolic Testing
    • 9.4.1 Overview
    • 9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pregnancy and Fertility
    • 9.5.1 Overview
    • 9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Rapid Test Kits Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospital and Clinics
    • 10.2.1 Overview
    • 10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Home-Care
    • 10.4.1 Overview
    • 10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Rapid Test Kits Market - Country Analysis

  • 11.1 North America: Rapid Test Kits Market
    • 11.1.1 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 United States
        • 11.1.1.1.1 Overview
      • 11.1.1.2 United States: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.1 United States: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.2.2 United States: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.2.3 United States: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.2.4 United States: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.2.4.1 United States: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.2.5 United States: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.3 Canada
        • 11.1.1.3.1 Overview
      • 11.1.1.4 Canada: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.4.1 Canada: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.4.2 Canada: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.4.3 Canada: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.4.4 Canada: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.4.4.1 Canada: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.4.5 Canada: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.5 Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.1 Overview
      • 11.1.1.6 Mexico
        • 11.1.1.6.1 Mexico: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.6.2 Mexico: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.6.3 Mexico: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.6.4 Mexico: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.6.4.1 Mexico: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.6.5 Mexico: Rapid Test Kits Market Breakdown, by End User

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Rapid Test Kit Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 F. Hoffmann-La Roche Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Becton Dickinson and Co
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 ARKRAY Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Fujirebio Europe NV
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 bioMerieux SA
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Cepheid
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Meril Life Sciences Pvt Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 QIAGEN NV
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 OraSure Technologies Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Guangzhou Wondfo Biotech Co Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Denka Co Ltd
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Abbott Laboratories
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Trinity Biotech Plc
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 SD Biosensor Inc
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Bio-Rad Laboratories Inc
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 Hologic Inc
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 DiaSorin SpA
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 Beckman Coulter Inc
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners